Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 29,768 shares at $36.77 ($1.1M) on 2021-11-22, disclosed to the SEC on 2021-11-23.
Open-market sale of $1.1M ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.77 | 14,884 | $547K | 50.0% |
| 2 | $36.77 | 14,884 | $547K | 50.0% |
| Total | $36.77 avg | 29,768 | $1.1M | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |